# Novel Strategies for Reducing Burn Scar Itch

> **NCT06801626** · PHASE3 · RECRUITING · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 44 (estimated)

## Conditions studied

- Burn Scar
- Itch Scarring
- Wound

## Interventions

- **COMBINATION_PRODUCT:** Famotidine and 4% topical cromolyn sodium
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06801626
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-11-01
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2025-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06801626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06801626, "Novel Strategies for Reducing Burn Scar Itch". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06801626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*